BIO - Bio-Rad Laboratories, Inc.

NYSE - NYSE Delayed price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts5545
Avg. Estimate2.73.3413.7316.01
Low estimate2.533.2113.714.92
High estimate2.893.4913.817.15
Year ago EPS3.382.614.4213.73
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts4455
Avg. Estimate697.31M729.56M2.9B3.12B
Low estimate680.34M712.37M2.87B3.03B
High estimate706.44M747.3M2.94B3.18B
Year ago sales691.1M679.94M2.8B2.9B
Sales growth (year/est)0.90%7.30%3.60%7.50%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS2.82.783.453.54
Actual EPS3.382.63.313.34
Difference0.58-0.18-0.14-0.2
Surprise %20.70%-6.50%-4.10%-5.60%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate2.73.3413.7316.01
7 days ago2.73.3413.7316.01
30 days ago3.823.815.9818.11
60 days ago3.83.7715.9618.11
90 days ago3.83.7715.9618.11
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesBIOIndustrySector(s)S&P 500
Current qtr.-20.10%N/AN/AN/A
Next qtr.28.50%N/AN/AN/A
Current year-4.80%N/AN/AN/A
Next year16.60%N/AN/AN/A
Next 5 years (per annum)17.80%N/AN/AN/A
Past 5 years (per annum)27.25%N/AN/AN/A